HDAC inhibitors have been shown to inhibit cell proliferation [47], [48], [49], [50] and in combination with all-trans-retinoic acid to increase re-differentiation of human thyroid cancer cell lines [51]. This evidence concerns the gene HDAC9 and thyroid cancer.